JPH08214892A - Production of partial glyceride containing highly unsaturated fatty acid - Google Patents
Production of partial glyceride containing highly unsaturated fatty acidInfo
- Publication number
- JPH08214892A JPH08214892A JP7029746A JP2974695A JPH08214892A JP H08214892 A JPH08214892 A JP H08214892A JP 7029746 A JP7029746 A JP 7029746A JP 2974695 A JP2974695 A JP 2974695A JP H08214892 A JPH08214892 A JP H08214892A
- Authority
- JP
- Japan
- Prior art keywords
- fatty acid
- lipase
- unsaturated fatty
- highly unsaturated
- partial glyceride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000005456 glyceride group Chemical group 0.000 title claims abstract description 58
- 235000021122 unsaturated fatty acids Nutrition 0.000 title claims abstract description 34
- 150000004670 unsaturated fatty acids Chemical class 0.000 title claims abstract description 34
- 238000004519 manufacturing process Methods 0.000 title claims description 16
- 102000004882 Lipase Human genes 0.000 claims abstract description 46
- 108090001060 Lipase Proteins 0.000 claims abstract description 46
- 239000004367 Lipase Substances 0.000 claims abstract description 46
- 235000019421 lipase Nutrition 0.000 claims abstract description 46
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 44
- 238000006243 chemical reaction Methods 0.000 claims abstract description 25
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 11
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 32
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 29
- 239000003921 oil Substances 0.000 claims description 28
- 235000019198 oils Nutrition 0.000 claims description 28
- 235000011187 glycerol Nutrition 0.000 claims description 20
- 239000003925 fat Substances 0.000 claims description 18
- 235000019197 fats Nutrition 0.000 claims description 18
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 14
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 10
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims description 9
- 235000021323 fish oil Nutrition 0.000 claims description 7
- 235000021342 arachidonic acid Nutrition 0.000 claims description 5
- 229940114079 arachidonic acid Drugs 0.000 claims description 5
- 239000007795 chemical reaction product Substances 0.000 claims description 4
- 241001474374 Blennius Species 0.000 claims description 3
- 241000239366 Euphausiacea Species 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 3
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 3
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 3
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 3
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 3
- 235000013305 food Nutrition 0.000 abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 8
- 241000589540 Pseudomonas fluorescens Species 0.000 abstract description 7
- 238000003756 stirring Methods 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 3
- 239000000839 emulsion Substances 0.000 abstract description 3
- 230000004071 biological effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 20
- 238000000034 method Methods 0.000 description 17
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 229930195729 fatty acid Natural products 0.000 description 10
- 239000000194 fatty acid Substances 0.000 description 10
- 150000004665 fatty acids Chemical class 0.000 description 10
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 9
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 7
- 235000014593 oils and fats Nutrition 0.000 description 7
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- 239000002994 raw material Substances 0.000 description 5
- 241000589516 Pseudomonas Species 0.000 description 4
- 238000003965 capillary gas chromatography Methods 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 230000001804 emulsifying effect Effects 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- 235000014214 soft drink Nutrition 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000588881 Chromobacterium Species 0.000 description 2
- 101000968491 Pseudomonas sp. (strain 109) Triacylglycerol lipase Proteins 0.000 description 2
- 241000269851 Sarda sarda Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000000199 molecular distillation Methods 0.000 description 2
- 239000004533 oil dispersion Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 241000555825 Clupeidae Species 0.000 description 1
- 241001149724 Cololabis adocetus Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 241000276438 Gadus morhua Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 241000108056 Monas Species 0.000 description 1
- 241000235575 Mortierella Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241001504592 Trachurus trachurus Species 0.000 description 1
- 241000179532 [Candida] cylindracea Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- 235000014106 fortified food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 235000013324 preserved food Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、高度不飽和脂肪酸高含
有部分グリセリドの製造方法及び該グリセリドの用途に
関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for producing a partial glyceride having a high content of polyunsaturated fatty acids and an application of the glyceride.
【0002】[0002]
【従来の技術】近年、エイコサペンタエン酸(以下「E
PA」という)、ドコサヘキサエン酸(以下「DHA」
という)などの高度不飽和脂肪酸は、動脈硬化症、血栓
症などの成人病に対する予防効果や制ガン作用、学習能
の増強作用など、多くの生理活性作用を有することが報
告されており、医薬品、健康補助食品、特定保健用食品
などの素材として注目されている。2. Description of the Related Art In recent years, eicosapentaenoic acid (hereinafter referred to as "E
PA), docosahexaenoic acid (hereinafter "DHA")
It has been reported that polyunsaturated fatty acids such as) have many physiologically active effects such as a preventive effect against adult diseases such as arteriosclerosis and thrombosis, an anticancer effect, and a learning effect enhancing effect. , Has been attracting attention as a material for dietary supplements and foods for specified health uses.
【0003】最近では、DHAをゼラチンカプセルに充
填した健康補助食品以外にもハム、ソーセージ、ちく
わ、味噌、缶詰、キャンディー、清涼飲料水などの一般
食品に添加したDHA強化食品についても数多く開発が
進められている。しかし、DHA含有油脂を清涼飲料水
に添加する場合は、DHA含有油脂原料がマグロ、カツ
オ由来の魚油等であるため、水系に乳化することが極め
て困難である。このため、かなりの量の乳化剤を添加
し、分散、安定化させなければならないが、乳化剤の添
加量は、例えば350 mlのドリンク剤に対しては約15mg
(DHAとして約3.8mgが含まれるにすぎない)が限界
である。これでは、生理活性を有するほどのDHA量を
含めることができない。Recently, in addition to dietary supplements containing DHA in gelatin capsules, many developments have been made on DHA-enriched foods added to general foods such as ham, sausage, chikuwa, miso, canned foods, candies and soft drinks. Has been. However, when adding DHA-containing oils and fats to soft drinks, it is extremely difficult to emulsify them into an aqueous system because the DHA-containing oils and fats raw material is tuna, bonito-derived fish oil and the like. For this reason, a considerable amount of emulsifier must be added to disperse and stabilize, but the amount of emulsifier added is, for example, about 15 mg for a 350 ml drink.
The limit is (only about 3.8 mg included as DHA). In this, it is not possible to include an amount of DHA having physiological activity.
【0004】従って、生理活性効果が期待できる量のD
HAを清涼飲料水に添加するためには、乳化安定性に優
れたDHA含有油脂を開発する必要がある。ところで、
モノグリセリドが乳化作用を有することは、従来より知
られており、かかるモノグリセリドの製造方法は古くか
ら研究されている。即ち、現在では、工業的には主に油
脂とグリセリンとの混合物に約0.1%の金属触媒を加
え、攪拌しながら 200〜240℃の高温下で反応させてモ
ノグリセリドを合成する、いわゆるグリセロリシス法が
用いられている。Therefore, an amount of D which can be expected to have a physiologically active effect
In order to add HA to soft drinks, it is necessary to develop a DHA-containing oil / fat having excellent emulsion stability. by the way,
It has been conventionally known that monoglycerides have an emulsifying action, and methods for producing such monoglycerides have been studied for a long time. That is, at present, industrially, a mixture of oil and fat and glycerin is mainly mixed with about 0.1% of a metal catalyst and reacted at a high temperature of 200 to 240 ° C with stirring to synthesize a monoglyceride. Method is used.
【0005】しかし、上記合成法ではかなりの高温下で
反応させるため、パルミチン酸やステアリン酸などの飽
和脂肪酸のモノグリセリドや一価不飽和脂肪酸であるオ
レイン酸やエルシン酸などのモノグリセリドは品質よく
製造できるのに対し、DHA、EPAなどの高度不飽和
脂肪酸は多くの二重結合を有するため酸化や熱による重
合を受けやすく非常に不安定であることから、これらの
高度不飽和脂肪酸を含むモノグリセリドは、上記のグリ
セロリシス法により製造することが困難である。However, since the reaction is carried out at a considerably high temperature in the above-mentioned synthetic method, monoglycerides of saturated fatty acids such as palmitic acid and stearic acid and monoglycerides such as oleic acid and erucic acid which are monounsaturated fatty acids can be produced with good quality. On the other hand, since highly unsaturated fatty acids such as DHA and EPA have many double bonds and are susceptible to polymerization by oxidation or heat and are very unstable, monoglycerides containing these highly unsaturated fatty acids are It is difficult to produce by the above glycerolysis method.
【0006】そこで、最近では反応条件が温和な酵素を
用いて天然油脂を加水分解し、モノグリセリドを製造す
る方法が注目されている。この方法では、油脂の加水分
解過程において、ある程度のモノグリセリドを蓄積する
ことは可能である。しかし、分解の進行とともにモノグ
リセリドも加水分解され、工業的コストに見合う十分量
のモノグリセリドを製造することが困難である。Therefore, recently, attention has been focused on a method for producing a monoglyceride by hydrolyzing natural fats and oils using an enzyme under mild reaction conditions. According to this method, it is possible to accumulate a certain amount of monoglyceride in the hydrolysis process of fats and oils. However, as the decomposition progresses, the monoglyceride is also hydrolyzed, and it is difficult to produce a sufficient amount of monoglyceride commensurate with the industrial cost.
【0007】一方、山根らは牛脂とグリセリンからなる
反応混液にクロモバクテリウム属(Chromobacterium)及
びシュードモナス属(Pseudomonas) などの微生物由来
のリパーゼを用いてグリセロリシス反応を行うと、約70
%のモノグリセリドが蓄積することを報告(JAOCS, Vo
l.67, no.11, 1990, JAOCS, Vol.68, no.1, 1991)して
いるが、DHA、EPAなどの高度不飽和脂肪酸を含有
する魚油を原料としてグリセロリシス反応法によってモ
ノグリセリドを製造できるか否かについては明らかでは
ない。On the other hand, Yamane et al performed a glycerolysis reaction using lipase derived from microorganisms such as the genus Chromobacterium in the reaction mixture consisting of beef tallow and glycerol (Chromobacterium) and Pseudomonas (Pseudomonas), about 70
% Monoglyceride accumulation reported (JAOCS, Vo
l.67, no.11, 1990, JAOCS, Vol.68, no.1, 1991), but monoglyceride is produced by the glycerolysis reaction method from fish oil containing highly unsaturated fatty acids such as DHA and EPA. It's unclear if they can.
【0008】[0008]
【発明が解決しようとする課題】本発明は、魚油、グリ
セリン及び少量の水を原料として、乳化作用にすぐれ、
かつ、高度不飽和脂肪酸を高濃度に含有する部分グリセ
リドの製造方法を提供することを目的とする。The present invention uses fish oil, glycerin and a small amount of water as raw materials and has an excellent emulsifying action,
Moreover, it aims at providing the manufacturing method of the partial glyceride which contains highly unsaturated fatty acid in high concentration.
【0009】[0009]
【課題を解決するための手段】本発明者らは、部分グリ
セリドが優れた乳化力を有することに着目し、高度不飽
和脂肪酸を高濃度に含有する油脂を原料とした部分グリ
セリドの製造法について鋭意研究を行った結果、油脂及
びグリセリンを含む溶液にリパーゼを作用させることに
より、食品に添加可能で乳化安定性に優れ、かつ、生理
活性を有する高度不飽和脂肪酸高含有部分グリセリドを
製造することに成功し、本発明を完成するに至った。Means for Solving the Problems The present inventors have focused on the fact that partial glycerides have an excellent emulsifying power, and are concerned with a method for producing partial glycerides using fats and oils containing highly unsaturated fatty acids in high concentrations as raw materials. As a result of earnest research, by reacting a solution containing fats and oils and glycerin with a lipase, it is possible to produce a highly unsaturated fatty acid-rich partial glyceride that can be added to foods, has excellent emulsion stability, and has physiological activity. And succeeded in completing the present invention.
【0010】すなわち、本発明は、油脂に、グリセリン
の存在下でリパーゼを作用させ、30℃から5℃まで段階
的に温度を下げながら反応を行うことを特徴とする高度
不飽和脂肪酸高含有部分グリセリドの製造方法である。
さらに、本発明は、油脂をリパーゼで加水分解し、得ら
れる反応生成物から高度不飽和脂肪酸高含有グリセリド
を得、該グリセリドに、グリセリンの存在下でリパーゼ
を作用させ、30℃から5℃まで段階的に温度を下げなが
ら反応を行い、部分グリセリドを得ることを特徴とする
高度不飽和脂肪酸高含有部分グリセリドの製造方法であ
る。That is, the present invention is characterized in that fats and oils are allowed to react with lipase in the presence of glycerin to carry out the reaction while gradually lowering the temperature from 30 ° C. to 5 ° C. It is a method for producing glycerides.
Furthermore, the present invention hydrolyzes oils and fats with lipase, obtains a highly unsaturated fatty acid-rich glyceride from the resulting reaction product, and causes lipase to act on the glyceride in the presence of glycerin to give a glycerin content of 30 ° C to 5 ° C. A method for producing a partial glyceride containing a high degree of polyunsaturated fatty acid, characterized in that the reaction is carried out while gradually lowering the temperature to obtain a partial glyceride.
【0011】さらに、本発明は、油脂をリパーゼで加水
分解し、得られる反応生成物から高度不飽和脂肪酸高含
有グリセリドを得、該グリセリドから分画して得られる
ジグリセリドに、グリセリンの存在下でリパーゼを作用
させ、30℃から5℃まで段階的に温度を下げながら反応
を行い、モノグリセリドを得ることを特徴とする高度不
飽和脂肪酸高含有部分グリセリドの製造方法である。Furthermore, the present invention hydrolyzes oils and fats with lipase to obtain a glyceride containing a high content of highly unsaturated fatty acids from the reaction product obtained, and diglyceride obtained by fractionating the glyceride in the presence of glycerin. A method for producing a partial glyceride having a high polyunsaturated fatty acid content, characterized in that a monoglyceride is obtained by reacting with lipase and gradually lowering the temperature from 30 ° C to 5 ° C.
【0012】ここで、部分グリセリドとは、モノグリセ
リド及び/又はジグリセリドであり、高度不飽和脂肪酸
としてはドコサヘキサエン酸、エイコサペンタエン酸若
しくはアラキドン酸又はこれらの組合わせが挙げられ、
油脂としては、魚油又はオキアミ、海藻若しくは菌類か
ら抽出したものが挙げられる。さらに、本発明は、上記
高度不飽和脂肪酸高含有部分グリセリドを含んでなる乳
化剤である。Here, the partial glyceride is a monoglyceride and / or a diglyceride, and the highly unsaturated fatty acid includes docosahexaenoic acid, eicosapentaenoic acid or arachidonic acid, or a combination thereof.
Examples of the oils and fats include fish oil or those extracted from krill, seaweed or fungi. Furthermore, the present invention is an emulsifier comprising the above-mentioned highly unsaturated fatty acid-rich partial glyceride.
【0013】以下、本発明を詳細に説明する。本発明で
は、まず、魚油等の油脂、グリセリン及び少量の水を含
む反応混液にリパーゼを加え、30℃から5℃まで段階的
に徐々に冷却しながらグリセロリシス反応を行うことに
よって高度不飽和脂肪酸高含有部分グリセリドを製造す
る。本発明での部分グリセリドとは、トリグリセリド以
外のグリセリド、即ち、ジグリセリド若しくはモノグリ
セリド、又はジグリセリドとモノグリセリドとの混合物
を意味する。また、高度不飽和脂肪酸とは、3個以上の
二重結合を有する炭素数20以上の脂肪酸、例えば、アラ
キドン酸(20:4) 、EPA(20:5)、及びDHA
(22:6) などが挙げられる。Hereinafter, the present invention will be described in detail. In the present invention, first, lipase is added to a reaction mixture containing oils and fats such as fish oil, glycerin and a small amount of water, and a glycerolysis reaction is performed while gradually cooling gradually from 30 ° C to 5 ° C, whereby a highly unsaturated fatty acid content is increased. A partial glyceride containing is produced. The partial glyceride in the present invention means a glyceride other than triglyceride, that is, diglyceride or monoglyceride, or a mixture of diglyceride and monoglyceride. Further, a polyunsaturated fatty acid is a fatty acid having 20 or more carbon atoms having 3 or more double bonds, for example, arachidonic acid (20: 4), EPA (20: 5), and DHA.
(22: 6).
【0014】さらに、本発明での油脂とは、構成脂肪酸
に高度不飽和脂肪酸を高濃度に含有し、好ましくはDH
A30%以上を含むものである。例えば、マグロ、カツ
オ、イワシ、サバ、アジ、サンマ、タラ、イカ等の魚油
の他にオキアミ、さらに、クロレラ、スピルリナ等の海
藻、モルティエラ属等の菌類等から抽出した油脂を挙げ
ることができる。Further, the oil and fat according to the present invention means that the constituent fatty acids contain a high concentration of highly unsaturated fatty acids, and preferably DH.
A containing 30% or more. For example, in addition to fish oils such as tuna, bonito, sardines, mackerel, horse mackerel, saury, cod, and squid, oils and fats extracted from krill, seaweeds such as chlorella and spirulina, and fungi such as Mortierella can be mentioned.
【0015】したがって、高度不飽和脂肪酸高含有部分
グリセリドとは、高度不飽和脂肪酸を高濃度に構成脂肪
酸として含むジグリセリド若しくはモノグリセリド又は
これらの混合物を意味するものである。本発明では、油
脂、グリセリン及び少量の水を含む混液を出発原料とす
ることができる。Therefore, the highly unsaturated fatty acid-rich partial glyceride means a diglyceride or monoglyceride containing a highly unsaturated fatty acid in a high concentration as a constituent fatty acid, or a mixture thereof. In the present invention, a mixed liquid containing fats and oils, glycerin and a small amount of water can be used as a starting material.
【0016】本発明で用いるリパーゼは、例えばシュー
ドモナス(Pseudomonas)属に属する微生物由来のリパー
ゼ等を用いることができる。かかるリパーゼについて
は、市販のものを用いることができる。例えば、シュー
ドモナス・フルオレッセンス(Pseudomonas fluoresce
nce) のリパーゼ(天野製薬(株),リパーゼAK)、
シュードモナス属(Pseudomonas sp.) のリパーゼ(天
野製薬(株),リパーゼP)等が挙げられる。As the lipase used in the present invention, for example, a lipase derived from a microorganism belonging to the genus Pseudomonas can be used. As such a lipase, a commercially available one can be used. For example, Pseudomonas fluorescens (Pseudomonas fluoresce
nce ) lipase (Amano Pharmaceutical Co., Ltd., Lipase AK),
Examples thereof include Pseudomonas sp. Lipase (Amano Pharmaceutical Co., Lipase P).
【0017】これらのリパーゼの使用形態はそのままで
もよいが、固定化剤(例えば、セライトやセラミックス
担体等)に固定化したリパーゼを使用してもよく、特に
限定されるものではない。リパーゼの使用量は、反応条
件によって適宜決定すればよく、特に制限されるもので
はない。例えば、油(トリグリセリド)1mol に対し
て、グリセリン2〜5mol 加え、反応混液1g当たり20
0〜10,000Uのリパーゼを使用することができる。ま
た、水分量については、例えば、油(トリグリセリド)
5gに対して10〜500 μl、好ましくは10〜200 μl 加
えることができる。The use form of these lipases may be as it is, but a lipase immobilized on an immobilizing agent (for example, Celite, a ceramic carrier, etc.) may be used and is not particularly limited. The amount of lipase used may be appropriately determined depending on the reaction conditions and is not particularly limited. For example, add 2 to 5 mol of glycerin to 1 mol of oil (triglyceride), and add 20 mol per 1 g of the reaction mixture.
0 to 10,000 U of lipase can be used. Regarding the water content, for example, oil (triglyceride)
10 to 500 µl, preferably 10 to 200 µl can be added to 5 g.
【0018】反応は、次の通り行う。すなわち、油脂
に、グリセリンの存在下でリパーゼを作用させ、30℃か
ら5℃まで段階的に温度を下げながらグリセロリシス反
応により行う。この場合、まず30℃で2〜10時間反応を
行い、次に室温(15〜25℃)で16時間反応を行う。更に
得られた反応液を5℃に冷却して24〜120時間反応を行
う。The reaction is carried out as follows. That is, the lipase is allowed to act on the oil or fat in the presence of glycerin, and the temperature is lowered stepwise from 30 ° C to 5 ° C by a glycerolysis reaction. In this case, first, the reaction is performed at 30 ° C for 2 to 10 hours, and then at room temperature (15 to 25 ° C) for 16 hours. Further, the obtained reaction solution is cooled to 5 ° C. and reacted for 24 to 120 hours.
【0019】反応終了後の溶液から高度不飽和脂肪酸高
含有部分グリセリドを抽出する。抽出は、通常の方法、
例えば、アルカリ脱酸法、溶剤液々分配法等により行
う。尚、脂質組成の分析は、例えば、ガスクロマトグラ
フィー、イヤトロスキャン法等により行う。DHAを高
濃度含む部分グリセリドを製造するには、まず、油脂を
リパーゼで選択的加水分解し、DHA高含有油脂を製造
し、これをグリセリンの存在下、リパーゼを用いてグリ
セロリシスを行う。A partial glyceride rich in highly unsaturated fatty acids is extracted from the solution after the reaction. Extraction is the usual method,
For example, an alkali deoxidizing method, a solvent liquid distribution method, or the like is used. The analysis of the lipid composition is performed by, for example, gas chromatography, ear troscan method, or the like. In order to produce a partial glyceride containing a high concentration of DHA, first, an oil or fat is selectively hydrolyzed with a lipase to produce an oil or fat having a high DHA content, and this is subjected to glycerolysis using the lipase in the presence of glycerin.
【0020】すなわち、油脂に、リパーゼ(例えばキャ
ンディダ・シリンドラシエ(Candida cylindracea) の
リパーゼ等)を作用させて30℃〜40℃で15〜70時間加水
分解反応を行い、高度不飽和脂肪酸高含有グリセリドを
得る。そして、該グリセリドからジグリセリドを分画す
る。分画方法としては、通常の方法、例えば、シリカゲ
ルカラムクロマトグラフィー、分子蒸留、真空精密蒸留
等が挙げられる。That is, a lipase (for example, lipase of Candida cylindracea ) is allowed to act on fats and oils to carry out a hydrolysis reaction at 30 ° C to 40 ° C for 15 to 70 hours to give a highly unsaturated fatty acid-rich glyceride. To get Then, diglyceride is fractionated from the glyceride. Examples of the fractionation method include ordinary methods such as silica gel column chromatography, molecular distillation and vacuum precision distillation.
【0021】次に、得られる高度不飽和脂肪酸高含有グ
リセリド又は該グリセリドから分画したジグリセリド
に、グリセリンの存在下で再度リパーゼを作用させ、30
℃から5℃まで段階的に温度を下げながら、前記方法と
同様にしてグリセロリシス反応を行う。ここで使用する
リパーゼとしては、上記加水分解用のリパーゼとは異な
るリパーゼ、例えば、シュードモナス・フルオレッセン
ス(Pseudomonas fluorescens)のリパーゼ(天野製薬
(株),リパーゼAK)、シュードモナス属(Pseudomo
nas sp.) のリパーゼ(天野製薬(株),リパーゼP)
等を用いる。Next, the obtained highly-unsaturated fatty acid-rich glyceride or diglyceride fractionated from the glyceride is allowed to act again with lipase in the presence of glycerin to give 30
The glycerolysis reaction is carried out in the same manner as the above method, while gradually lowering the temperature from ℃ to 5 ℃. As the lipase used here, a lipase different from the above-mentioned lipase for hydrolysis, for example, lipase of Pseudomonas fluorescens (Amano Pharmaceutical Co., Ltd., Lipase AK), Pseudomonas genus ( Pseudomo )
nas sp.) lipase (Amano Pharmaceutical Co., Ltd., Lipase P)
Etc. are used.
【0022】脂質分析、脂肪酸組成の分析については、
前記と同様である。一回目の加水分解により、グリセリ
ド画分にDHAを40〜50%含有するDHA高含有ジグリ
セリドが得られる。このジグリセリドを用いて2回目の
リパーゼ反応を行うことにより、よりDHA含量の高い
部分グリセリドが得られる。本発明によって生成された
部分グリセリドは、反応混液からアルカリ洗浄、分子蒸
留、真空精密蒸留、水蒸気蒸留、溶剤液液分配、低温結
晶化分別、クロマトグラフィー等の処理、又はこれらの
処理を適宜組み合わせることによって精製分画できる。Regarding lipid analysis and fatty acid composition analysis,
The same as above. The first hydrolysis gives a DHA-rich diglyceride containing 40 to 50% of DHA in the glyceride fraction. By performing the second lipase reaction using this diglyceride, a partial glyceride having a higher DHA content can be obtained. The partial glyceride produced by the present invention is subjected to treatment such as alkali washing, molecular distillation, vacuum precision distillation, steam distillation, solvent liquid-liquid distribution, low temperature crystallization fractionation, chromatography, etc., from the reaction mixture, or a combination thereof. Can be purified and fractionated.
【0023】このようにして得られた高度不飽和脂肪酸
高含有部分グリセリドは、主としてモノグリセリド及び
/又はジグリセリドにより構成されており、アラキドン
酸、DHA、EPAなどの高度不飽和脂肪酸を高濃度に
含む。アラキドン酸、EPA及びDHA等は、循環器系
及び中枢神経系機能に関与する、生体に必須の脂肪酸で
あるため、本発明によって製造される高度不飽和脂肪酸
高含有部分グリセリドは、医薬品、健康補助食品又は特
定保健用食品として、また、部分グリセリドが非常に優
れた乳化剤であるため、上記の生理活性作用を有する乳
化剤として極めて有用である。The thus-obtained highly unsaturated fatty acid-rich partial glyceride is mainly composed of monoglycerides and / or diglycerides, and contains highly unsaturated fatty acids such as arachidonic acid, DHA, and EPA at high concentrations. Arachidonic acid, EPA, DHA and the like are essential fatty acids in the living body that are involved in the functions of the circulatory system and the central nervous system. Therefore, the highly unsaturated fatty acid-rich partial glyceride produced by the present invention is used as a drug or a health supplement. It is extremely useful as a food or a food for specified health use, and since the partial glyceride is an extremely excellent emulsifier, it is extremely useful as an emulsifier having the above physiologically active action.
【0024】[0024]
【実施例】以下、本発明を実施例により更に具体的に説
明する。但し、本発明は、これら実施例に限定されるも
のではない。 〔実施例1〕マグロ油(ケン化価:184.2, EPA:5.
8%,DHA:23.3%) 100gとグリセリン20g(モル比で
1:2) 及び蒸留水5mlを含む反応系にシュードモナス
・フルオレッセンス(Pseudomonas fluorescens) のリ
パーゼ(天野製薬(株) 製、リパーゼAK、26,800U/g)を
50,000U(ユニット) 加え、攪拌しながら反応させた。反
応は30℃で5時間、室温で16時間、次いで5℃で24時間
行った。EXAMPLES The present invention will be described in more detail below with reference to examples. However, the present invention is not limited to these examples. [Example 1] Tuna oil (saponification value: 184.2, EPA: 5.
8%, DHA: 23.3%) 100 g, glycerin 20 g (molar ratio 1: 2), and distilled water 5 ml in the reaction system Pseudomonas fluorescens ( Pseudomonas fluorescens ) lipase (Amano Pharmaceutical Co., Ltd., Lipase AK, 26,800 U / g)
50,000 U (unit) was added and reacted with stirring. The reaction was carried out at 30 ° C. for 5 hours, room temperature for 16 hours and then at 5 ° C. for 24 hours.
【0025】得られた反応混液を適量採取し、クロマロ
ットS-III( (株) ヤトロン製) にスポットし、ベンゼ
ン:クロロホルム:酢酸(50:20:0.5(v/v)) の混合溶
媒で展開してからイヤトロスキャンTH-10 ((株) ヤトロ
ン製) で脂質組成の分析を行った。その結果、脂質組成
はトリグリセリド (TG) 26.1%、脂肪酸 (FFA) 6.8%、
ジグリセリド (DG) 33.0%、モノグリセリド(MG) 34.1
%(重量%)であった。An appropriate amount of the obtained reaction mixture was sampled, spotted on Chromalot S-III (manufactured by Yatron Co., Ltd.), and developed with a mixed solvent of benzene: chloroform: acetic acid (50: 20: 0.5 (v / v)). After that, the lipid composition was analyzed by using Iatroscan TH-10 (manufactured by Yatron Co., Ltd.). As a result, the lipid composition was triglyceride (TG) 26.1%, fatty acid (FFA) 6.8%,
Diglyceride (DG) 33.0%, Monoglyceride (MG) 34.1
% (% By weight).
【0026】このように魚油トリグリセリドの約70%が
モノグリセリド及びジグリセリドに変換できることがわ
かった。得られた反応混液中の遊離脂肪酸はアルカリ脱
酸法により水層に除去し、トリグリセリド、ジグリセリ
ド、モノグリセリドからなるグリセリド混合物90.8g を
得た。グリセリド混合物中の脂肪酸組成は常法に従いメ
チルエステル化した後、キャピラリーガスクロマトグラ
フィーにより分析した。It was thus found that about 70% of fish oil triglycerides can be converted into monoglycerides and diglycerides. The free fatty acid in the obtained reaction mixture was removed to the aqueous layer by the alkaline deoxidation method to obtain 90.8 g of a glyceride mixture consisting of triglyceride, diglyceride and monoglyceride. The fatty acid composition in the glyceride mixture was methyl esterified by a conventional method and then analyzed by capillary gas chromatography.
【0027】その結果、EPA 5.7%、DHA24.6%で
あった。得られたグリセリド混合物は、原料としたマグ
ロ油に比べ、乳化分散性及び安定性が飛躍的に向上して
おり、ドリンク剤 350mlに対して、他の乳化剤を使用し
なくても60mg(DHAとして14.8mg) の添加が可能であ
った。この乳化剤は5℃及び25℃で60日間密封保存して
も油の分散や沈澱物の生成はまったく見られなかった。
尚、5℃の保存において魚臭の発臭はまったくなかっ
た。As a result, EPA was 5.7% and DHA was 24.6%. The obtained glyceride mixture has dramatically improved emulsification dispersibility and stability compared to the tuna oil used as the raw material, and 60 mg (as DHA without using other emulsifiers per 350 ml of the drink). 14.8 mg) could be added. This emulsifier did not show any oil dispersion or precipitate formation even after being sealed and stored at 5 ° C. and 25 ° C. for 60 days.
There was no fishy odor during storage at 5 ° C.
【0028】〔実施例2〕マグロ油(ケン化価:184.2,
EPA:5.8%,DHA:23.3%) 100g、水 100g及
びキャンディダ・シリンドラシェ(Candida cylindrac
ea) のリパーゼ(名糖産業(株)製、リパーゼOF、360,
000U/g) 0.2gからなる反応混液を攪拌しながら30℃で16
時間加水分解反応を行った。加水分解後の反応液は十分
平衡に達していた。[Example 2] Tuna oil (saponification value: 184.2,
EPA: 5.8%, DHA: 23.3%) 100g, water 100g and Candida cylindrac
ea ) lipase (manufactured by Meito Sangyo Co., Ltd., Lipase OF, 360,
(000U / g) 16g at 30 ℃ while stirring the reaction mixture consisting of 0.2g.
The hydrolysis reaction was performed for a time. The reaction liquid after hydrolysis reached a sufficient equilibrium.
【0029】次いで、該反応液からリパーゼを含む水層
を除去して加水分解油を得た。(加水分解油の酸価は13
2.1であった。) さらに、該加水分解油から遊離した脂
肪酸をアルカリ脱酸法によって水層に除去し、高度不飽
和脂肪酸濃縮グリセリドを33.5g(収率33.5%) 得た。
この高度不飽和脂肪酸濃縮グリセリドの酸価は0.1であ
った。脂肪酸組成は、常法に従いメチルエステル化した
後、キャピラリーガスクロマトグラフィーで分析した。
その結果、構成脂肪酸中のEPAは5.1%、DHAは4
7.8%であった。また、実施例1と同様にイヤトロスキ
ャンで脂質組成の分析を行った結果、トリグリセリド
(TG) 85.3%、ジグリセリド (DG) 12.9%、モノグリセ
リド (MG) 1.8%であった。Then, the aqueous layer containing lipase was removed from the reaction solution to obtain a hydrolyzed oil. (The acid value of hydrolyzed oil is 13
2.1. ) Further, fatty acids liberated from the hydrolyzed oil were removed to the aqueous layer by an alkaline deoxidation method to obtain 33.5 g (yield 33.5%) of highly unsaturated fatty acid concentrated glyceride.
The acid value of this highly unsaturated fatty acid concentrated glyceride was 0.1. The fatty acid composition was analyzed by capillary gas chromatography after methyl esterification according to a conventional method.
As a result, EPA in constituent fatty acids was 5.1% and DHA was 4%.
It was 7.8%. Further, as a result of analyzing the lipid composition by an ear scan in the same manner as in Example 1, triglyceride
(TG) was 85.3%, diglyceride (DG) was 12.9%, and monoglyceride (MG) was 1.8%.
【0030】このグリセリド混合物30g をシリカゲルカ
ラムクロマトグラフィーにより3.5gジグリセリド画分を
精製単離した。このジグリセリドを常法に従いメチルエ
ステル化した後、キャピラリーガスクロマトグラフィー
で分析した。その結果、EPAは4.1%、DHAは53.2
%であった。30 g of this glyceride mixture was purified and isolated by silica gel column chromatography to obtain 3.5 g of diglyceride fraction. This diglyceride was methyl-esterified by a conventional method and then analyzed by capillary gas chromatography. As a result, EPA was 4.1% and DHA was 53.2.
%Met.
【0031】次に、得られたジグリセリド3g とグリセ
リン0.4g (モル比で1:1) 及び蒸留水 150μl を含
む反応系にシュードモナス・フルオレッセンス(Pseudo
monas fluorescens) のリパーゼ(天野製薬(株) 製、リ
パーゼAK、26,800U/g)を1,500U (ユニット) 加え、攪拌
しながら反応させた。反応は30℃で5時間、室温で16時
間、次いで5℃で24時間行った。Next, Pseudomonas fluorescens ( Pseudo ) was added to a reaction system containing 3 g of the obtained diglyceride, 0.4 g of glycerin (molar ratio 1: 1) and 150 μl of distilled water.
monas fluorescens) lipase (Amano Pharmaceutical Co. Ltd., Lipase AK, 26,800U / g) was added 1,500U (units) was allowed to react with stirring. The reaction was carried out at 30 ° C. for 5 hours, room temperature for 16 hours and then at 5 ° C. for 24 hours.
【0032】得られた反応混液を実施例1と同様にイヤ
トロスキャンで脂質組成の分析を行ったところ、脂質組
成は TG 18.8%、 FFA 6.5%、 DG 49.0%、 MG 25.7%
(重量%)であった。このように、マグロ油をリパーゼ
で選択的加水分解して得られた高度不飽和脂肪酸高含有
油脂から、シリカゲルカラムクロマトグラフィーにより
単離精製したジグリセリドについても、上記グリセロリ
シス反応により約25%モノグリセリド(MG) に変換させ
られることができた。The reaction mixture obtained was analyzed for lipid composition by an ear scan in the same manner as in Example 1. The lipid composition was TG 18.8%, FFA 6.5%, DG 49.0%, MG 25.7%.
(% By weight). Thus, diglyceride isolated and purified by silica gel column chromatography from highly unsaturated fatty acid-rich fats and oils obtained by selectively hydrolyzing tuna oil with lipase, about 25% monoglyceride (MG ) Could be converted to.
【0033】得られた反応混液中の遊離脂肪酸はアルカ
リ脱酸法により水層に除去し、トリグリセリド、ジグリ
セリド、モノグリセリドからなるグリセリド混合物2.8g
を得た。グリセリド混合物中の脂肪酸組成は、常法に従
いメチルエステル化した後、キャピラリーガスクロマト
グラフィーにより分析した。The free fatty acid in the obtained reaction mixture was removed to the aqueous layer by the alkaline deoxidation method, and 2.8 g of a glyceride mixture consisting of triglyceride, diglyceride and monoglyceride.
I got The fatty acid composition in the glyceride mixture was analyzed by capillary gas chromatography after methyl esterification according to a conventional method.
【0034】その結果、EPA 4.5%、DHA53.8%で
あった。得られたグリセリド混合物は、原料としたマグ
ロ油に比べ、乳化分散性及び安定性が飛躍的に向上して
おり、ドリンク剤 350mlに対して他の乳化剤を使用しな
くても60mg(DHAとして32.5mg) の添加が可能であっ
た。この乳化剤は5℃及び25℃で60日間密封保存しても
油の分散や沈澱物の生成はまったく見られなかった。
尚、5℃の保存において魚臭の発臭はまったくなかっ
た。As a result, the EPA was 4.5% and the DHA was 53.8%. The resulting glyceride mixture has dramatically improved emulsification dispersibility and stability compared to the tuna oil used as the raw material, and 60 mg (32.5 as DHA 32.5 ml) for 350 ml of the drink without using any emulsifier. (mg) could be added. This emulsifier did not show any oil dispersion or precipitate formation even after being sealed and stored at 5 ° C. and 25 ° C. for 60 days.
There was no fishy odor during storage at 5 ° C.
【0035】[0035]
【発明の効果】本発明により、高度不飽和脂肪酸高含有
部分グリセリドを効率的に製造する方法を提供すること
ができる。水系への乳化分散性及び安定性が極めて優
れ、かつ、生理活性を有する高度不飽和脂肪酸高含有部
分グリセリドを効率良く製造できることは、医薬品、化
粧品、特定保健用食品及び一般食品などに幅広く利用す
ることが可能であり、産業上極めて有用てある。INDUSTRIAL APPLICABILITY The present invention can provide a method for efficiently producing a partial glyceride having a high content of highly unsaturated fatty acids. Efficient production of highly unsaturated fatty acid-rich partial glycerides that have extremely excellent emulsifying dispersibility and stability in aqueous systems and that have physiological activity is widely used for pharmaceuticals, cosmetics, foods for specified health uses, and general foods. It is possible and extremely useful in industry.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 丸山 一輝 茨城県つくば市和台16番2 マルハ株式会 社中央研究所内 (72)発明者 椎名 智香子 茨城県つくば市和台16番2 マルハ株式会 社中央研究所内 (72)発明者 中山 秀 茨城県つくば市和台16番2 マルハ株式会 社中央研究所内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Kazuki Maruyama 16-2 Wadai, Tsukuba-shi, Ibaraki Maruha Stock Company Central Research Institute (72) Inventor Chikako Shiina 16-2 Wadai, Tsukuba-shi, Ibaraki Maruha Stock Company Central Research Institute (72) Inventor Hide Nakayama 16-2 Wadai, Tsukuba, Ibaraki Maruha Stock Company Central Research Laboratories
Claims (7)
を作用させ、30℃から5℃まで段階的に温度を下げなが
ら反応を行うことを特徴とする高度不飽和脂肪酸高含有
部分グリセリドの製造方法。1. A method for producing a partial glyceride having a high content of highly unsaturated fatty acids, which comprises reacting fats and oils with lipase in the presence of glycerin to carry out the reaction while gradually lowering the temperature from 30 ° C. to 5 ° C. .
反応生成物から高度不飽和脂肪酸高含有グリセリドを
得、該グリセリドに、グリセリンの存在下でリパーゼを
作用させ、30℃から5℃まで段階的に温度を下げながら
反応を行い、部分グリセリドを得ることを特徴とする高
度不飽和脂肪酸高含有部分グリセリドの製造方法。2. A fat or oil is hydrolyzed with a lipase to obtain a highly unsaturated fatty acid-rich glyceride from the resulting reaction product, and the glycerin is allowed to act with lipase in the presence of glycerin to give a step from 30 ° C. to 5 ° C. A method for producing a partial glyceride having a high polyunsaturated fatty acid content, characterized in that a partial glyceride is obtained by carrying out a reaction while lowering the temperature.
反応生成物から高度不飽和脂肪酸高含有グリセリドを
得、該グリセリドから分画して得られるジグリセリド
に、グリセリンの存在下でリパーゼを作用させ、30℃か
ら5℃まで段階的に温度を下げながら反応を行い、モノ
グリセリドを得ることを特徴とする高度不飽和脂肪酸高
含有部分グリセリドの製造方法。3. An oil or fat is hydrolyzed with a lipase to obtain a glyceride having a high content of polyunsaturated fatty acids from the resulting reaction product, and the diglyceride obtained by fractionating the glyceride is reacted with the lipase in the presence of glycerin. A method for producing a partial glyceride having a high content of highly unsaturated fatty acids, characterized in that the reaction is carried out while gradually lowering the temperature from 30 ° C to 5 ° C to obtain a monoglyceride.
/又はジグリセリドである請求項1〜3のいずれかの項
記載の高度不飽和脂肪酸高含有部分グリセリドの製造方
法。4. The method for producing a partial glyceride having a high polyunsaturated fatty acid content according to claim 1, wherein the partial glyceride is a monoglyceride and / or a diglyceride.
酸、エイコサペンタエン酸若しくはアラキドン酸又はこ
れらの組合わせである請求項1〜3のいずれかの項記載
の高度不飽和脂肪酸高含有部分グリセリドの製造方法。5. The method for producing a partial glyceride rich in highly unsaturated fatty acid according to claim 1, wherein the highly unsaturated fatty acid is docosahexaenoic acid, eicosapentaenoic acid, arachidonic acid or a combination thereof. .
は菌類から抽出したものである請求項1〜3のいずれか
の項記載の高度不飽和脂肪酸高含有部分グリセリドの製
造方法。6. The method for producing a partial glyceride having a high polyunsaturated fatty acid content according to claim 1, wherein the oil or fat is extracted from fish oil, krill, seaweed or fungi.
不飽和脂肪酸高含有部分グリセリドの製造方法によって
得られた高度不飽和脂肪酸高含有部分グリセリドを含ん
でなる乳化剤。7. An emulsifier comprising a highly unsaturated fatty acid-rich partial glyceride obtained by the method for producing a highly unsaturated fatty acid-rich partial glyceride according to any one of claims 1 to 3.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7029746A JPH08214892A (en) | 1995-02-17 | 1995-02-17 | Production of partial glyceride containing highly unsaturated fatty acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7029746A JPH08214892A (en) | 1995-02-17 | 1995-02-17 | Production of partial glyceride containing highly unsaturated fatty acid |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH08214892A true JPH08214892A (en) | 1996-08-27 |
Family
ID=12284672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7029746A Pending JPH08214892A (en) | 1995-02-17 | 1995-02-17 | Production of partial glyceride containing highly unsaturated fatty acid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH08214892A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998018952A1 (en) * | 1996-10-30 | 1998-05-07 | Nippon Suisan Kaisha, Ltd. | Process for producing fats containing highly unsaturated fatty acids containing selectively concentrated docosahexaenoic acid |
WO2000003031A1 (en) * | 1998-07-09 | 2000-01-20 | Kao Corporation | Process for producing partial glyceride |
US6448292B2 (en) | 2000-03-21 | 2002-09-10 | Kao Corporation | Oil composition |
WO2004052115A1 (en) * | 2002-12-06 | 2004-06-24 | Abbott Laboratories | Glyceride compositions and methods of making and using same |
US6762203B2 (en) | 1999-08-03 | 2004-07-13 | Kao Corporation | Oil composition |
US6956058B2 (en) | 2001-04-26 | 2005-10-18 | Kao Corporation | Method for improving insulin resistance |
JP2008113671A (en) * | 1996-10-11 | 2008-05-22 | Suntory Ltd | Edible oil containing arachidonic acid originating from microorganism, food additive composed of the same, and food containing the same and method for producing this edible oil containing arachidonic acid |
WO2011149040A1 (en) | 2010-05-28 | 2011-12-01 | 日本水産株式会社 | Process for production of oil or fat containing highly unsaturated fatty acid using lipase |
WO2020050303A1 (en) * | 2018-09-04 | 2020-03-12 | 日本水産株式会社 | Production method for highly unsaturated fatty acid-containing glyceride using lipase hydrolysis reaction |
-
1995
- 1995-02-17 JP JP7029746A patent/JPH08214892A/en active Pending
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008113671A (en) * | 1996-10-11 | 2008-05-22 | Suntory Ltd | Edible oil containing arachidonic acid originating from microorganism, food additive composed of the same, and food containing the same and method for producing this edible oil containing arachidonic acid |
WO1998018952A1 (en) * | 1996-10-30 | 1998-05-07 | Nippon Suisan Kaisha, Ltd. | Process for producing fats containing highly unsaturated fatty acids containing selectively concentrated docosahexaenoic acid |
WO2000003031A1 (en) * | 1998-07-09 | 2000-01-20 | Kao Corporation | Process for producing partial glyceride |
US6337414B1 (en) * | 1998-07-09 | 2002-01-08 | Kao Corporation | Process for producing partial glyceride |
US6852758B2 (en) | 1999-08-03 | 2005-02-08 | Kao Corporation | Oil composition |
US6762203B2 (en) | 1999-08-03 | 2004-07-13 | Kao Corporation | Oil composition |
US6448292B2 (en) | 2000-03-21 | 2002-09-10 | Kao Corporation | Oil composition |
US6956058B2 (en) | 2001-04-26 | 2005-10-18 | Kao Corporation | Method for improving insulin resistance |
WO2004052115A1 (en) * | 2002-12-06 | 2004-06-24 | Abbott Laboratories | Glyceride compositions and methods of making and using same |
WO2011149040A1 (en) | 2010-05-28 | 2011-12-01 | 日本水産株式会社 | Process for production of oil or fat containing highly unsaturated fatty acid using lipase |
KR20130111233A (en) | 2010-05-28 | 2013-10-10 | 닛폰 스이산 가부시키가이샤 | Process for production of oil or fat containing highly unsaturated fatty acid using lipase |
US10138502B2 (en) | 2010-05-28 | 2018-11-27 | Nippon Suisan Kaisha, Ltd. | Method for producing oil containing polyunsaturated fatty acid using lipase |
WO2020050303A1 (en) * | 2018-09-04 | 2020-03-12 | 日本水産株式会社 | Production method for highly unsaturated fatty acid-containing glyceride using lipase hydrolysis reaction |
US11840714B2 (en) | 2018-09-04 | 2023-12-12 | Nissui Corporation | Enriching DHA in glyceride fractions |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6537787B1 (en) | Enzymatic methods for polyunsaturated fatty acid enrichment | |
DK2006389T3 (en) | Process for preparing concentrated polyunsaturated fatty acid oil | |
KR100684642B1 (en) | Glyceride oil composition from fish oil and preparation method thereof | |
JP4522257B2 (en) | Process for producing transesterified oil or fat or triglyceride | |
JPH09510091A (en) | Essential oil composition | |
KR20130111233A (en) | Process for production of oil or fat containing highly unsaturated fatty acid using lipase | |
CN101037641A (en) | Process for producing fat comprising triglyceride containing highly unsaturated fatty acid | |
JP7365346B2 (en) | Method for producing glyceride containing highly unsaturated fatty acids using lipase hydrolysis reaction | |
JPH08214892A (en) | Production of partial glyceride containing highly unsaturated fatty acid | |
JP3840459B2 (en) | Glyceride and method for producing the same | |
JP3340182B2 (en) | Method for producing triglyceride containing docosahexaenoic acid | |
JP3689443B2 (en) | Process for producing highly unsaturated fatty acid-containing glycerides | |
JP5237627B2 (en) | Method for concentrating highly unsaturated fatty acids | |
JP2007089522A (en) | Method for producing fatty acid composition containing specific highly unsaturated fatty acid in concentrated state | |
JPH0860181A (en) | Highly unsaturated fatty acid-containing oil and fat | |
JPH08214891A (en) | Production of oil and fat containing highly unsaturated fatty acid-containing triglyceride | |
JP4310387B2 (en) | Omega-3 highly unsaturated fatty acid-containing partial glyceride composition and method for producing the same | |
JPH11263750A (en) | Long-chain unsaturated fatty acid menthol ester and its production by enzyme method | |
JP3861941B2 (en) | Oil composition containing highly unsaturated fatty acid with improved hydration | |
JPH0913075A (en) | Oil and fat for diminishing lipid in blood | |
Zheng et al. | Enzymatic preparation of mono-and diacylglycerols: A review | |
FR2652588A1 (en) | PROCESS FOR PRODUCING A MIXTURE OF GLYCERIDES ENRICHED WITH FATTY ACIDS | |
JPH07268382A (en) | Production of fats and oils containing long-chain highly unsaturated fatty acid | |
JP3544247B2 (en) | Pharmaceutical composition for inhibiting platelet aggregation | |
Lie et al. | Esterification of polyunsaturated fatty acids with lipases from different sources |